Volux by Juvéderm Is About to Change the Jaw Filler Game

Volux is the first FDA-approved hyaluronic acid-based injectable filler that specifically targets the jawline, an area that Juvéderm’s parent company, Allergan Aesthetics, has discovered to be a key area of concern for many consumers. 

This approval broadens the Juvéderm filler collection and provides providers with more options to address their patients’ lower face aesthetic concerns,” Carrie Strom, president of Global Allergan Aesthetics, tells Allure.

This new filler will not be widely available in the United States until early 2023, with product training for dermatologists, plastic surgeons, and other aesthetic treatment professionals beginning this fall. In the meantime, we turned to the experts to find out what to expect when this new filler becomes available in medical offices.

What exactly does Volux do?

Volux basically defines the jawline. It’s a dermal filler made of hyaluronic acid, similar to other Juvéderm fillers like Voluma XC. According to Hadley King, MD, a New York City-based board-certified dermatologist and clinical instructor of dermatology at Cornell University’s Weill Medical College, the main differences are that Volux has more structure, cohesivity, and lift capacity. Strom adds that Volux is firmer than Voluma XC, providing the chiselled jawline that everyone desires.

How does it function?

According to Marisa Garshick, MD, a board-certified cosmetic dermatologist at MDCS Dermatology in New York City, hyaluronic acid filler is typically injected deep into the bone along the jawline and chin to add definition. She explains that the filler provides structural support and contours the jaw, giving it a more lifted appearance. While the amount injected depends on your specific face shape and how much your provider recommends, Dr. Garshick says you’ll notice a difference with just one syringe.

23rd World Dermatology Congress

Theme: Discovering the innovative techniques against major skin diseases and defects with the help of science

Conference URL: https://www.lexismeeting.com/dermatologycongress

Volux is intended for whom?

Anyone over the age of 21 will be eligible for treatment, though those with a history of multiple severe allergies or who are prone to allergic reactions to lidocaine or the gram-positive bacterial proteins found in this filler should avoid it. If you’ve had allergic reactions to other hyaluronic acid fillers, you should be wary of this one as well.

Are there any negative consequences?

You can expect similar side effects to other filler treatments, such as tenderness, swelling, lumps, and bruising, according to Dr. Garshick, but these should go away in about two weeks. Dr. King adds that other potential side effects of Volux — or any filler — include infection and vascular occlusion.

Dr. Garshick recommends avoiding ibuprofen, fish oils, and aspirin if you want to reduce bruising. You should also avoid alcohol and exercise for at least 24 hours after receiving this treatment, but always consult with your doctor about aftercare for the best results.

How long do the effects last?

As previously stated, results can be instantaneous and provide a discernible difference. Volux studies found improvement in jawline definition after six months, with results lasting up to a year and a half.

As a reminder, the filler will not be widely available until 2023, but stay tuned for more information.

Bella Winget

Program Manager | Dermatology Congress 2022

Whatsapp: +447915638336

Email- cardiologyinsights@globalannualsummit.com

Source by- https://www.allure.com/story/juvederm-volux-fda-approved-for-jaw-filler